These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 28726325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lupus erythematosus-like skin eruption after vemurafenib therapy.
    Reinholz M, Berking C, Hermans C, Ruzicka T, Braun-Falco M.
    J Am Acad Dermatol; 2014 Oct; 71(4):e159-60. PubMed ID: 25219748
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient.
    Karakas Y, Yuce D, Kılıckap S.
    Oncol Res Treat; 2017 Oct; 40(10):621-622. PubMed ID: 28950270
    [No Abstract] [Full Text] [Related]

  • 11. Nivolumab improves survival for patients with advanced lung cancer.
    Printz C.
    Cancer; 2017 Sep 01; 123(17):3211. PubMed ID: 28833027
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.
    Noda-Narita S, Mizuno S, Noguchi S, Watanabe K, Nakai Y, Koike K, Kage H, Nagase T.
    Eur J Cancer; 2019 Jan 01; 107():93-96. PubMed ID: 30554074
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
    Ko JH, Shih YC, Hui RC, Yang CH.
    J Clin Oncol; 2011 Mar 01; 29(7):e169-70. PubMed ID: 21149656
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.